Efficient anti-tumor nano-lipoplexes with unsaturated or saturated lipid induce differential genotoxic effects in mice

References

• Ahmad, A., S. K. Mondal, D. Mukhopadhyay, R. Banerjee, and K. M. Alkharfy. 2016. “Development of Liposomal Formulation for Delivering Anticancer Drug to Breast Cancer Stem-Cell-like Cells and Its Pharmacokinetics in an Animal Model.” Molecular Pharmaceutics 13(3): 1081–1088. doi:10.1021/acs.molpharmaceut.5b00900.
   PubMed Web of Science ®Google Scholar
• Alexander, J. F., D. Aguirre-Villarreal, and B. Godin. 2017. “Liposomal Encapsulation Masks Genotoxicity of a Chemotherapeutic Agent in Regulatory Toxicology Assessments.” Nanomedicine: Nanotechnology, Biology, and Medicine 13(3): 829–833. doi:10.1016/j.nano.2016.12.016.
   PubMed Web of Science ®Google Scholar
• Anselmo, A. C., and S. Mitragotri. 2016. “Nanoparticles in the Clinic.” Bioengineering & Translational Medicine 1(1): 10–29. doi:10.1002/btm2.10003.
   PubMed Web of Science ®Google Scholar
• AshaRani, P. V., G. Low Kah Mun, M. P. Hande, and S. Valiyaveettil. 2009. “Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells.” ACS Nano 3(2): 279–290. doi:10.1021/nn800596w.
   PubMed Web of Science ®Google Scholar
• Bulbake, U., S. Doppalapudi, N. Kommineni, and W. Khan. 2017. “Liposomal Formulations in Clinical Use: An Updated Review.” Pharmaceutics 9(4): 12. doi:10.3390/pharmaceutics9020012.
   PubMed Web of Science ®Google Scholar
• Chang, H., M. Cheng, and M. Yeh. 2012. “Clinically-Proven Liposome-Based Drug Delivery: Formulation Characterization and Therapeutic Efficacy.” Open Access Scientific Reports 1: 195. doi:10.4172/scientificreports.
   Google Scholar
• Conde, J., M. Larguinho, A. Cordeiro, L. R. Raposo, P. M. Costa, S. Santos, M. S. Diniz, A. R. Fernandes, and P. V. Baptista. 2014. “Gold-Nanobeacons for Gene Therapy: Evaluation of Genotoxicity, Cell Toxicity and Proteome Profiling Analysis.” Nanotoxicology 8(5): 521–532. doi:10.3109/17435390.2013.802821.
   PubMed Web of Science ®Google Scholar
• Deshpande, P. P., S. Biswas, and V. P. Torchilin. 2013. “Current Trends in the Use of Liposomes for Tumor Targeting.” Nanomedicine 8(9): 1509–1528. doi:10.2217/nnm.13.118.
   PubMed Web of Science ®Google Scholar
• Eichhorn, M. E., S. Becker, S. Strieth, A. Werner, B. Sauer, M. Teifel, H. Ruhstorfer, U. Michaelis, J. Griebel, and G. Brix. 2006. “Paclitaxel Encapsulated in Cationic Lipid Complexes (MBT-0206) Impairs Functional Tumor Vascular Properties as Detected by Dynamic Contrast Enhanced Magnetic Resonance Imaging.” Cancer Biology & Therapy 5(1): 89–96. doi:10.4161/cbt.5.1.2346.
   PubMed Web of Science ®Google Scholar
• Eichhorn, M. E., I. Ischenko, S. Luedemann, S. Strieth, A. Papyan, A. Werner, H. Bohnenkamp, E. Guenzi, G. Preissler, and U. Michaelis 2010. “Vascular Targeting by EndoTAG™‐1 Enhances Therapeutic Efficacy of Conventional Chemotherapy in Lung and Pancreatic Cancer.” International Journal of Cancer 126(5): 1235–1245. doi:10.1002/ijc.24846.
   PubMed Web of Science ®Google Scholar
• Hua, J., N. Gross, B. Schulze, U. Michaelis, H. Bohnenkamp, E. Guenzi, L. L. Hansen, G. Martin, and H. T. Agostini. 2012. “In Vivo Imaging of Choroidal Angiogenesis Using Fluorescence-Labeled Cationic Liposomes.” Molecular Vision 18: 1045.
   PubMed Web of Science ®Google Scholar
• Immordino, M. L., F. Dosio, and L. Cattel. 2006. “Stealth Liposomes: Review of the Basic Science, Rationale, and Clinical Applications, Existing and Potential.” International Journal of Nanomedicine 1(3): 297.
   PubMed Web of Science ®Google Scholar
• Knudsen, K. B., H. Northeved, P. Kumar Ek, A. Permin, T. Gjetting, T. L. Andresen, S. Larsen., et al. 2015. “In Vivo Toxicity of Cationic Micelles and Liposomes.” Nanomedicine: Nanotechnology, Biology and Medicine 11(2): 467–477. doi:10.1016/j.nano.2014.08.004.
   PubMed Web of Science ®Google Scholar
• Koynova, R., L. Wang, and R. C. MacDonald. 2006. “An Intracellular Lamellar–Nonlamellar Phase Transition Rationalizes the Superior Performance of Some Cationic Lipid Transfection Agents.” Proceedings of the National Academy of Sciences of the United States of America 103(39): 14373–14378. doi:10.1073/pnas.0603085103.
   PubMed Web of Science ®Google Scholar
• Lee, S. M., J. S. Kim, Y. K. Oh, Y. B. Lee, and H. Sah. 2005. “Biodistribution and Genotoxicity of Transferrin-Conjugated Liposomes/DNA Complexes in Mice.” Macromolecular Research 13(3): 218–222. doi:10.1007/BF03219055.
   Web of Science ®Google Scholar
• Marepally, S., V. Chandrashekhar, R. C. Reddy, R. Prabhakar, S. Bojja, and A. Chaudhuri. 2011. “The Influence of the Structural Orientation of Amide Linkers on the Serum Compatibility and Lung Transfection Properties of Cationic Amphiphiles.” Biomaterials 32 (22): 5231–5240. doi:10.1016/j.biomaterials.2011.03.059
   Google Scholar
• Meka, R. R., S. Godeshala, S. Marepally, K. Thorat, H. K. Reddy Rachamalla, A. Dhayani, A. Hiwale, R. Banerjee, A. Chaudhuri, and P. K. Vemula. 2016. “Asymmetric Cationic Lipid Based Non-Viral Vectors for an Efficient Nucleic Acid Delivery.” RSC Advances 6(81): 77841–77848. doi:10.1039/C6RA07256A.
   Web of Science ®Google Scholar
• Mondal, S. K., S. Jinka, K. Pal, S. Nelli, S. K. Dutta, E. Wang, A. Ahmad, K. M. AlKharfy, D. Mukhopadhyay, and R. Banerjee. 2016. “Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors.” Molecular Pharmaceutics 13(7): 2507–2523. doi:10.1021/acs.molpharmaceut.6b00230.
   PubMed Web of Science ®Google Scholar
• Pattni, B. S., V. V. Chupin, and V. P. Torchilin. 2015. “New Developments in Liposomal Drug Delivery.” Chemical Reviews 115(19): 10938–10966. doi:10.1021/acs.chemrev.5b00046.
   PubMed Web of Science ®Google Scholar
• Pore, S. K., A. Choudhary, B. Rathore, A. Ganguly, P. Sujitha, C. G. Kumar, S. B. Agawane, et al. 2013. “Hsp90-Targeted miRNA-Liposomal Formulation for Systemic Antitumor Effect.” Biomaterials 34(28): 6804–6817. doi:10.1016/j.biomaterials.2013.05.054.
   PubMed Web of Science ®Google Scholar
• Rosenblum, D., N. Joshi, W. Tao, J. M. Karp, and D. Peer. 2018. “Progress and Challenges towards Targeted Delivery of Cancer Therapeutics.” Nature Communications 9(1): 1410. doi:10.1038/s41467-018-03705-y.
   PubMed Web of Science ®Google Scholar
• Sinha, S., S. Roy, B. S. Reddy, K. Pal, G. Sudhakar, S. Iyer, S. Dutta, E. Wang, P. K. Vohra, K. R. Roy, et al. 2011. “A Lipid-Modified Estrogen Derivative That Treats Breast Cancer Independent of Estrogen Receptor Expression through Simultaneous Induction of Autophagy and Apoptosis.” Molecular Cancer Research 9(3): 364–374. doi:10.1158/1541-7786.MCR-10-0526.
   PubMed Web of Science ®Google Scholar
• Vasievich, E. A., W. Chen, and L. Huang. 2011. “Enantiospecific Adjuvant Activity of Cationic Lipid DOTAP in Cancer Vaccine.” Cancer Immunology, Immunotherapy 60(5): 629–638. doi:10.1007/s00262-011-0970-1.
   PubMed Web of Science ®Google Scholar
• Xie, H., M. M. Mason, and J. P. Wise, Sr. 2011. “Genotoxicity of Metal Nanoparticles.” Reviews on Environmental Health 26(4): 251–268.
   PubMedGoogle Scholar
• Zylberberg, C., K. Gaskill, S. Pasley, and S. Matosevic. 2017. “Engineering Liposomal Nanoparticles for Targeted Gene Therapy.” Gene Therapy 24(8): 441–452. doi:10.1038/gt.2017.41.
   PubMed Web of Science ®Google Scholar